Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant Diseases-Reference-Cited by-同舟云学术

Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant Diseases

Published:2015-02 Issue:2 Volume:21 Page:288-292
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Haines Hilary L.,Bleesing Jack J.,Davies Stella M.,Hornung Lindsey,Jordan Michael B.,Marsh Rebecca A.,Filipovich Alexandra H.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference18 articles.

1. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease;Hill;Blood,1986

2. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation;Mattsson;Transplantation,2001

3. Donor CD4 T cells convert mixed to full donor T-cell chimerism and replenish the CD52-positive T-cell pool after alemtuzumab-based T-cell-depleted allo-transplantation;Meyer;Bone Marrow Transplant,2010

4. Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism;Svenberg;Bone Marrow Transplant,2009

5. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence;van Besien;Leuk Lymphoma,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Prophylactic Donor Lymphocyte Infusion (DLI) in an Adult T Cell Lymphoma/Leukemia (ATLL) Patient—Modality of Relapse Prevention;Diseases;2024-09-11

2. Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients;Bone Marrow Transplantation;2024-08-12

3. Early withdrawal immunosuppression improved mixed chimerism in hematopoietic stem cell transplantation for pediatric aplastic anemia;2024-08-09

4. Treatment of Mixed Chimerism After Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major;American Journal of Pediatrics;2024-02-20

5. Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity;Transplantation and Cellular Therapy;2024-01